127 filings
Page 4 of 7
6-K
pu4ku
23 Nov 20
Current report (foreign)
8:45am
6-K
ekvn dcbw1ephnw
22 Oct 20
Current report (foreign)
6:01am
6-K
wap45z4z2l6i5kg
6 Oct 20
Current report (foreign)
7:54am
6-K
m2v085wtiqzdvkcv3n
31 Jul 20
Current report (foreign)
9:02am
6-K
b9wjlowhkw
30 Jul 20
Current report (foreign)
8:15am
6-K
ibsbstd3 42c7m5q1u
29 May 20
Current report (foreign)
4:24pm
6-K
bc429to7fnlma7s
26 May 20
Current report (foreign)
8:00am
6-K
jcx32 sz6wnie
14 May 20
Current report (foreign)
9:06am
6-K
z1jpv04bustgm5y44qg
12 May 20
Current report (foreign)
4:18pm
6-K
rt0djt
31 Mar 20
Current report (foreign)
9:01am
6-K
dffe 6bx2g28leuxr9i
27 Feb 20
Current report (foreign)
12:00am
6-K
wzgtczioajq7jd0ux
13 Jan 20
JP Morgan Healthcare Conference January 2020 – San Francisco
7:50am
6-K
wn7xtg
9 Jan 20
Current report (foreign)
8:00am
6-K
6wilq6xe u2k40
9 Dec 19
Current report (foreign)
8:08am
6-K
ba9nm2h631bf4
8 Nov 19
Current report (foreign)
5:18pm
6-K
gbwkc9y0dfrij36zj3i
6 Nov 19
Current report (foreign)
9:24am
6-K
p2575hb1pfz062x
24 Oct 19
Current report (foreign)
7:18am
6-K
czg1olxkviu1geld6dyu
15 Oct 19
Invitation to the extraordinary shareholders’ meeting
4:36pm
6-K
eknqxt5rvjwl2fixwkk
1 Aug 19
First of two registration trials from Phase 3 program of efgartigimod in primary immune thrombocytopenia (ITP) patients expected to start in 2H19
6:17am
6-K
66oii6 57
28 May 19
Current report (foreign)
6:09am